par Duquenne, J.;Mabalukwa, Junior ;Calvo, E.;Michaux, C.;Staub, Thérèse
Référence RMLG. Revue médicale de Liège, 73, 7-8, page (384-386)
Publication Publié, 2017
Article révisé par les pairs
Résumé : Strongyloidiasis is a parasitosis mainly located in tropical and subtropical regions. Its European incidence is increasing due to population migration. The symptomato-logy is variable, largely depending on the host immune status. The diagnosis may be challenging as a specific inquiry is needed. The disseminated status, called hyperinfection syndrome, is a life-threatening disease that might occur in immunosuppressed patients. The patient's chances for a successful outcome depend on a quick and specific management. The treatment is based on anthelminthic agents such as ivermectine or albendazole for which the dosage will vary according to the infection type.

Documents en relation

DI-fusion